Paul Brett, Ph.D.

Professor, w88 online casino and Immunology
Paul Brett
Development of vaccines and diagnostics to combat melioidosis and glanders

Summary

Professional Biography

  • 2017 - present: Associate Professor, w88 online casino and Immunology, University of Nevada, Reno School of Medicine, Reno, NV, USA
  • 2014 - 2017: Associate Professor, w88 online casino and Immunology, University of South Alabama, College of Medicine, Mobile, AL, USA:
  • 2008 - 2014: Assistant Professor, w88 online casino and Immunology, University of South Alabama, College of Medicine, Mobile, AL, USA
  • 2003 - 2008: Visiting Fellow, Laboratory of Zoonotic Pathogens, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT, USA
  • 2001 - 2003: w88 online casino Scientist and Project Leader, Quorex Pharmaceuticals, Inc., Carlsbad, CA, USA
  • 2000 - 2001: Postdoctoral Fellow, w88 online casino and Infectious Diseases, University of Calgary, Calgary, AB, Canada
  • 1999 - 2000: Postdoctoral Fellow, Department of Medical Microbiology, w88 online casino College London, London, United Kingdom

w88 online casino Interests

Research in the Brett laboratory is focused on elucidating the w88 online casino mechanisms used by Burkholderia pseudomallei (melioidosis) and Burkholderia mallei (glanders) to evade clearance by host defenses. In particular, we are interested in determining how the lipopolysaccharides and capsular polysaccharides expressed by these organisms contribute to this process. Our laboratory has over 20 years of experience working with these important bacterial pathogens and has gained significant expertise in areas relating to Burkholderia genetics, pathogenesis, host-pathogen interactions, carbohydrate purification/characterization, glycoconjugate synthesis and the analysis of humoral/cellular immune responses. The main goal of our w88 online casino is to identify correlates of antigen-induced immunity against B. pseudomallei and B. mallei and use this information to develop safe, affordable and effective melioidosis/glanders vaccines. Our laboratory is currently funded by the Defense Threat Reduction Agency (DTRA) to develop and test i) melioidosis and glanders subunit vaccine candidates and ii) serological assays to rapidly diagnose active cases of melioidosis.

Current Lab Members

  • Sineenart Sengyee, Ph.D., w88 online casino Assistant Professor
  • Federico Urbano-Munoz, Staff w88 online casino Associate III
  • Jacob Loughry, Staff w88 online casino AssociateII
  • Sarah Weiby, CMB Graduate Student

Past Lab Members

  • Teresa Shaffer Ph.D., Postdoctoral Fellow
  • Lindsey Schmidt, Ph.D., Graduate Student
  • Caitlyn Orne, Ph.D.

Education

  • 1998 - Ph.D., Bacterial Pathogenesis, w88 online casino Calgary, Canada
  • 1993 - B.Sc., Biochemistry, w88 online casino Victoria, Canada